Pierce™ Protease Inhibitor Tablets, EDTA - -50mL solution - 20 tablets -A32965/PIA32965

A32965/PIA32965 - Pierce™ Protease Inhibitor Tablets, EDTA - 20 tablets

Description

Pierce Protease Inhibitor Tablets protect proteins from proteolytic degradation through inhibition of the serine-proteases, cysteine-proteases, aspartic acid-proteases and aminopeptidases that are typically present in cellular lysate samples. The tablets contain AEBSF, aprotinin, bestatin, E-64, leupeptin and pepstatin A. Stable for storage at 4°C for up to 12 months, each mini or large tablet tablet is sufficient for 10mL or 50mL of solution, respectively, and is suitable for reagent preparation prior to protein extraction from tissue and cultured cells.

Highlights:

• Improved formulation&mdsashtablets dissolve quickly into a clear solution
• Economical – more cost-effective than other commercially available formulations for equivalent volumes
• Convenient&mdsashready-to-use, fully disclosed, broad-spectrum formulations
• Compatible&mdsashuse directly with Thermo Scientific™ Pierce™ BCA Assays
• EDTA-free- formulated without EDTA, a metalloproteinase inhibitor (only for EDTA-free formulations)